Dose-response study of the analgesic effect of lanepitant in patients with painful diabetic neuropathy

Clinical Neuropharmacology

Volumn 24, Issue 1, 2001, Pages 16-22

  Goldstein, David J ^a,b,c   Wang, Ouhong ^a   Gitter, Bruce D ^a   Iyengar, Smriti ^a  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c METHODIST HOSPITAL   (United States)

Author keywords

Analgesia; Double blind; Nociception; Placebo; Substance P; Tachykinin

Indexed keywords

LANEPITANT;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

AGED; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; PAIN MEASUREMENT; PIPERIDINES; RECEPTORS, NEUROKININ-1;

EID: 0035117131     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200101000-00004     Document Type: Article

References (15)

1. 3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists
2. The nonpeptide NK-1 receptor antagonists LY303870 and LY306740 block the responses of spinal dorsal horn neurons to substance P and to peripheral noxious stimuli
3. RP-67580, a specific tachykinin NK-1 receptor antagonist, relieves chronic hyperalgesia in diabetic rats
4. LY303870 a centrally active neurokinin-1 antagonist with a long duration of action
5. The formalin test: An evaluation of the method
6. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy
7. Study of the analgesic effect of lanepitant in patients with osteoarthritis pain
8. The MOS 36-item short-form health survey (SF-36). I: Conceptual framework and item selection
9. Receptors and antagonists for substance P and related peptides
10. Synaptic relationship between substance P and the substance P receptor: Light and electron microscopic characterization of the mismatch between neuropeptides and their receptors
11. Review of the effectiveness of Capsaicin for painful cutaneous disorders and neural dysfunction
12. Substance P receptor antagonist CP-99,994 reduces acute postoperative pain
13. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
14. Interaction between substance P and excitatory amino acid receptors in modulation of nociceptive responses of cat spinal dorsal horn neurons
15. Substance P modulates glutamate-induced currents in acutely isolated rat spinal dorsal horn neurones